Patents by Inventor Vinayagam Kannan

Vinayagam Kannan has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • EPINEPHRINE FORMULATIONS
    Publication number: 20240091176
    Abstract: Pharmaceutical compositions comprising epinephrine, methods of administration, and methods of making the same. Compositions may comprise at least one of an active agent, a pH raising agent, an antioxidant, a transition metal complexing agent, a pH lowering agent, a tonicity regulating agent, optionally a preservative, and optionally a solvent.
    Type: Application
    Filed: September 19, 2023
    Publication date: March 21, 2024
    Inventors: Suketu Sanghvi, Vinayagam Kannan, Matthew Kenney
  • EPINEPHRINE FORMULATIONS
    Publication number: 20240058281
    Abstract: Pharmaceutical compositions comprising epinephrine, methods of administration, and methods of making the same. Compositions may comprise at least one of an active agent, a pH raising agent, an antioxidant, a transition metal complexing agent, a pH lowering agent, a tonicity regulating agent, optionally a preservative, and optionally a solvent.
    Type: Application
    Filed: September 28, 2023
    Publication date: February 22, 2024
    Inventors: Suketu SANGHVI, Vinayagam KANNAN, Matthew KENNEY
  • VASOPRESSIN FORMULATIONS FOR USE IN TREATMENT OF HYPOTENSION
    Publication number: 20230256048
    Abstract: Provided herein are peptide formulations comprising polymers as stabilizing agents. The peptide formulations can be more stable for prolonged periods of time at temperatures higher than room temperature when formulated with the polymers. The polymers used in the present invention can decrease the degradation of the constituent peptides of the peptide formulations.
    Type: Application
    Filed: July 11, 2022
    Publication date: August 17, 2023
    Inventors: Matthew Kenney, Vinayagam Kannan, Sunil Vandse, Suketu Sanghvi
  • EPINEPHRINE FORMULATIONS
    Publication number: 20230100523
    Abstract: Pharmaceutical compositions comprising epinephrine, methods of administration, and methods of making the same. Compositions may comprise at least one of an active agent, a pH raising agent, an antioxidant, a transition metal complexing agent, a pH lowering agent, a tonicity regulating agent, optionally a preservative, and optionally a solvent.
    Type: Application
    Filed: March 2, 2022
    Publication date: March 30, 2023
    Inventors: Suketu SANGHVI, Vinayagam KANNAN, Matthew KENNEY
  • Epinephrine formulations
    Patent number: 11337938
    Abstract: Pharmaceutical compositions comprising epinephrine, methods of administration, and methods of making the same. Compositions may comprise at least one of an active agent, a pH raising agent, an antioxidant, a transition metal complexing agent, a pH lowering agent, a tonicity regulating agent, optionally a preservative, and optionally a solvent.
    Type: Grant
    Filed: March 12, 2020
    Date of Patent: May 24, 2022
    Assignee: PAR PHARMACEUTICAL, INC.
    Inventors: Suketu Sanghvi, Vinayagam Kannan, Matthew Kenney
  • VASOPRESSIN FORMULATIONS FOR USE IN TREATMENT OF HYPOTENSION
    Publication number: 20220133838
    Abstract: Provided herein are peptide formulations comprising polymers as stabilizing agents. The peptide formulations can be more stable for prolonged periods of time at temperatures higher than room temperature when formulated with the polymers. The polymers used in the present invention can decrease the degradation of the constituent peptides of the peptide formulations.
    Type: Application
    Filed: September 10, 2021
    Publication date: May 5, 2022
    Inventors: Matthew Kenney, Vinayagam Kannan, Sunil Vandse, Suketu Sanghvi
  • Vasopressin formulations for use in treatment of hypotension
    Patent number: 11207372
    Abstract: Provided herein are peptide formulations comprising polymers as stabilizing agents. The peptide formulations can be more stable for prolonged periods of time at temperatures higher than room temperature when formulated with the polymers. The polymers used in the present invention can decrease the degradation of the constituent peptides of the peptide formulations.
    Type: Grant
    Filed: March 4, 2019
    Date of Patent: December 28, 2021
    Assignee: PAR PHARMACEUTICAL, INC.
    Inventors: Matthew Kenney, Vinayagam Kannan, Sunil Vandse, Suketu Sanghvi
  • Vasopressin formulations for use in treatment of hypotension
    Patent number: 11135265
    Abstract: Provided herein are peptide formulations comprising polymers as stabilizing agents. The peptide formulations can be more stable for prolonged periods of time at temperatures higher than room temperature when formulated with the polymers. The polymers used in the present invention can decrease the degradation of the constituent peptides of the peptide formulations.
    Type: Grant
    Filed: March 4, 2019
    Date of Patent: October 5, 2021
    Assignee: PAR PHARMACEUTICAL, INC.
    Inventors: Matthew Kenney, Vinayagam Kannan, Sunil Vandse, Suketu Sanghvi
  • PEPTIDE CONGENERS WITH POLYMER EXCIPIENTS
    Publication number: 20210077568
    Abstract: Provided herein are peptide formulations comprising polymers as stabilizing agents. The peptide formulations can be more stable for prolonged periods of time at temperatures higher than room temperature when formulated with the polymers. The polymers used in the present invention can decrease the degradation of the constituent peptides of the peptide formulations.
    Type: Application
    Filed: November 25, 2020
    Publication date: March 18, 2021
    Inventors: Matthew Kenney, Vinayagam Kannan, Sunil Vandse, Suketu Sanghvi
  • EPINEPHRINE FORMULATIONS
    Publication number: 20200206163
    Abstract: Pharmaceutical compositions comprising epinephrine, methods of administration, and methods of making the same. Compositions may comprise at least one of an active agent, a pH raising agent, an antioxidant, a transition metal complexing agent, a pH lowering agent, a tonicity regulating agent, optionally a preservative, and optionally a solvent.
    Type: Application
    Filed: March 12, 2020
    Publication date: July 2, 2020
    Inventors: Suketu SANGHVI, Vinayagam KANNAN, Matthew KENNEY
  • PEPTIDE CONGENERS WITH POLYMER EXCIPIENTS
    Publication number: 20200188474
    Abstract: Provided herein are peptide formulations comprising polymers as stabilizing agents. The peptide formulations can be more stable for prolonged periods of time at temperatures higher than room temperature when formulated with the polymers. The polymers used in the present invention can decrease the degradation of the constituent peptides of the peptide formulations.
    Type: Application
    Filed: October 16, 2018
    Publication date: June 18, 2020
    Inventors: Matthew Kenney, Vinayagam Kannan, Sunil Vandse, Suketu Sanghvi
  • Epinephrine formulations
    Patent number: 10624864
    Abstract: Pharmaceutical compositions comprising epinephrine, methods of administration, and methods of making the same. Compositions may comprise at least one of an active agent, a pH raising agent, an antioxidant, a transition metal complexing agent, a pH lowering agent, a tonicity regulating agent, optionally a preservative, and optionally a solvent.
    Type: Grant
    Filed: January 25, 2019
    Date of Patent: April 21, 2020
    Assignee: PAR PHARMACEUTICAL, INC.
    Inventors: Suketu Sanghvi, Vinayagam Kannan, Matthew Kenney
  • VASOPRESSIN FORMULATIONS FOR USE IN TREATMENT OF HYPOTENSION
    Publication number: 20190201476
    Abstract: Provided herein are peptide formulations comprising polymers as stabilizing agents. The peptide formulations can be more stable for prolonged periods of time at temperatures higher than room temperature when formulated with the polymers. The polymers used in the present invention can decrease the degradation of the constituent peptides of the peptide formulations.
    Type: Application
    Filed: March 20, 2019
    Publication date: July 4, 2019
    Inventors: Matthew Kenney, Vinayagam Kannan
  • VASOPRESSIN FORMULATIONS FOR USE IN TREATMENT OF HYPOTENSION
    Publication number: 20190192615
    Abstract: Provided herein are peptide formulations comprising polymers as stabilizing agents. The peptide formulations can be more stable for prolonged periods of time at temperatures higher than room temperature when formulated with the polymers. The polymers used in the present invention can decrease the degradation of the constituent peptides of the peptide formulations.
    Type: Application
    Filed: March 4, 2019
    Publication date: June 27, 2019
    Inventors: Matthew Kenney, Vinayagam Kannan, Sunil Vandse, Suketu Sanghvi
  • VASOPRESSIN FORMULATIONS FOR USE IN TREATMENT OF HYPOTENSION
    Publication number: 20190192616
    Abstract: Provided herein are peptide formulations comprising polymers as stabilizing agents. The peptide formulations can be more stable for prolonged periods of time at temperatures higher than room temperature when formulated with the polymers. The polymers used in the present invention can decrease the degradation of the constituent peptides of the peptide formulations.
    Type: Application
    Filed: March 4, 2019
    Publication date: June 27, 2019
    Inventors: Matthew Kenney, Vinayagam Kannan, Sunil Vandse, Suketu Sanghvi
  • EPINEPHRINE FORMULATIONS
    Publication number: 20190151261
    Abstract: Pharmaceutical compositions comprising epinephrine, methods of administration, and methods of making the same. Compositions may comprise at least one of an active agent, a pH raising agent, an antioxidant, a transition metal complexing agent, a pH lowering agent, a tonicity regulating agent, optionally a preservative, and optionally a solvent.
    Type: Application
    Filed: January 25, 2019
    Publication date: May 23, 2019
    Inventors: Suketu SANGHVI, Vinayagam KANNAN, Matthew KENNEY
  • EPINEPHRINE FORMULATIONS
    Publication number: 20190105288
    Abstract: Pharmaceutical compositions comprising epinephrine, methods of administration, and methods of making the same. Compositions may comprise at least one of an active agent, a pH raising agent, an antioxidant, a transition metal complexing agent, a pH lowering agent, a tonicity regulating agent, optionally a preservative, and optionally a solvent.
    Type: Application
    Filed: December 5, 2018
    Publication date: April 11, 2019
    Inventors: Suketu Sanghvi, Vinayagam Kannan, Matthew Kenney
  • VASOPRESSIN FORMULATIONS FOR USE IN TREATMENT OF HYPOTENSION
    Publication number: 20180333453
    Abstract: Provided herein are peptide formulations comprising polymers as stabilizing agents. The peptide formulations can be more stable for prolonged periods of time at temperatures higher than room temperature when formulated with the polymers. The polymers used in the present invention can decrease the degradation of the constituent peptides of the peptide formulations.
    Type: Application
    Filed: July 24, 2018
    Publication date: November 22, 2018
    Inventors: Matthew Kenney, Vinayagam Kannan
  • VASOPRESSIN FORMULATIONS FOR USE IN TREATMENT OF HYPOTENSION
    Publication number: 20180333454
    Abstract: Provided herein are peptide formulations comprising polymers as stabilizing agents. The peptide formulations can be more stable for prolonged periods of time at temperatures higher than room temperature when formulated with the polymers. The polymers used in the present invention can decrease the degradation of the constituent peptides of the peptide formulations.
    Type: Application
    Filed: July 24, 2018
    Publication date: November 22, 2018
    Inventors: Matthew Kenney, Vinayagam Kannan
  • Epinephrine formulations
    Patent number: 10130592
    Abstract: Pharmaceutical compositions comprising epinephrine, methods of administration, and methods of making the same. Compositions may comprise at least one of an active agent, a pH raising agent, an antioxidant, a transition metal complexing agent, a pH lowering agent, a tonicity regulating agent, optionally a preservative, and optionally a solvent.
    Type: Grant
    Filed: September 23, 2015
    Date of Patent: November 20, 2018
    Assignee: PAR PHARMACEUTICAL, INC.
    Inventors: Vinayagam Kannan, Patrick Irish, Michael Bergren